What’s in a name? Over the past year, we’ve come to realize that our business is quickly evolving. Our focus has always been on delivering healthcare system solutions and when we founded Accelera Medtech Canada, we specifically wanted to bring innovative medical devices to the Canadian market. However, one of the things we’ve learned in speaking with potential partners over 2020 was that devices were only part of the solution for the challenges facing healthcare.
While this seems like a significant change, our core beliefs haven’t changed. Over the last few months, we have thought long and hard about creating a new name that would convey who we are, and what we seek to accomplish. In the spirit of rebranding, we will continue to commit to our customers and partners that we provide the same high level of professionalism you have experienced, and we’d like to take the opportunity to thank our loyal customers and business partners for your trust and friendship in our business.
As Noviscend expands its product portfolio in Canada, we will continue to focus our business development activities on branded prescription products and medical devices that are in late-stage development, or currently approved and commercialized outside Canada, or approved in Canada but falling outside the license holder’s business focus. Our therapeutic categories of interest for proprietary products will continue to include neurology, psychiatry, dermatology, pain management, and women's health - although we may consider other opportunities outside of these areas if there is a strategic rationale.
As you notice changes in our branding, we would certainly appreciate hearing from you. If you use social media, please connect with us that way. And as always, feel free to reach out with any thoughts or questions any time.
CEO, Kostas Trakas stated “As part of our focus on delivering innovative healthcare solutions, our leadership team and I believe it was appropriate to rebrand our company and are very excited about the introduction of our new company name, Noviscend Inc., because it allows us to better represent our aspirations to both our consumers and partners.”
About Noviscend Inc.
Headquartered in Mississauga, Ontario, Canada, Noviscend Inc.’s mission is to acquire and commercialize innovative devices and pharmaceuticals in targeted therapeutic areas with high unmet needs in Canada.
For more information regarding this announcement, please contact:
Noviscend Inc.
Kostas Trakas
Chief Executive Officer
+1-289-497-9447
ktrakas@noviscend.com